Exelixis reported $0.27 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.

Fiscal Calendar Actual Consensus Previous Date
FY2024Q1 Mar/2024 0.23 0.12 Apr/30 2024
FY2023Q4 Dec/2023 0.33 0.23 -0.09 Feb/06 2024
FY2023Q3 Sep/2023 0.10 0.15 0.23 Nov/01 2023
FY2023Q2 Jun/2023 0.25 0.16 0.22 Aug/01 2023
FY2023Q1 Mar/2023 0.12 0.15 0.21 May/09 2023
FY2022Q4 Dec/2022 -0.09 -0.11 0.29 Feb/07 2023
FY2022Q3 Sep/2022 0.23 0.18 0.12 Nov/01 2022
FY2022Q2 Jun/2022 0.22 0.16 0.3 Aug/09 2022
FY2022Q1 Mar/2022 0.21 0.14 0 May/10 2022
FY2021Q4 Dec/2021 0.29 0.04 0.09 Feb/17 2022
FY2021Q3 Sep/2021 0.12 0.16 -0.1 Nov/02 2021
FY2021Q2 Jun/2021 0.3 0.06 0.21 Aug/05 2021

Eps Change Date
Acadia Pharmaceuticals USD 0.28 0.68 Dec/2023
Agios Pharmaceuticals USD -1.72 0.08 Dec/2023
Amgen USD 4.71 0.25 Dec/2023
AstraZeneca USD 1.45 0.28 Dec/2023
Bayer EUR 1.85 1.47 Dec/2023
BioMarin Pharmaceutical USD 0.71 0.53 Mar/2024
Bristol-Myers Squibb USD -4.4 6.1 Mar/2024
Cytokinetics USD -1.38 0.03 Dec/2023
Eisai JPY 20.82 11.1 Dec/2023
Eli Lilly USD 2.49 2.39 Dec/2023
Exelixis USD 0.27 0.17 Dec/2023
Genmab DKK 9.67 22.65 Dec/2023
Glaxosmithkline USD 0.72 0.56 Dec/2023
Incyte USD 1.06 0.04 Dec/2023
Ionis Pharmaceuticals USD -0.06 0.97 Dec/2023
MacroGenics USD -0.75 1.03 Dec/2023
Merck USD 2.07 2.04 Mar/2024
Moderna USD 0.55 10.08 Dec/2023
Neurocrine Biosciences USD 1.44 0.62 Dec/2023
Novartis USD 1.8 0.27 Mar/2024
Pfizer USD 0.1 0.27 Dec/2023
Sanofi USD 0.89 1.88 Dec/2023
Takeda JPY 67.59 98.59 Dec/2023
Ultragenyx Pharmaceutical USD -1.52 0.71 Dec/2023
Xencor USD -0.31 0.09 Dec/2023